TRH and Hyperglycemia: rhGH increased mortality in critically ill patients. The authors hypothesize that this toxicity is explained by the induction of insulin resistance, hyperglycemia, and low thyroid hormone level. Therefore, a combination of GHRP2, TRH, and insulin may result in favorable outcomes.